Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide, Bortezomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT01212952Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Sep 2011
- Primary completion
- Aug 2017
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of pomalidomide in multiple myeloma (MM), sponsored by Mayo Clinic. Started Sep 2011; status: completed.
02
Drugs
pomalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01212952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01212952.